Preventice offers customized capabilities and reading methodologies using varied degrees of automation and manual application of cardiac expertise to meet regulatory needs. Analyses typically include interval measurements, such as PR, RR, QRS, QT, QTcB and QTcF, QT correction formulas, and other clinical ECG interpretation. All diagnostic data are analyzed by Certified Cardiac Technicians and Certified Rhythm Analysis Technicians at Preventice Independent Diagnostic Testing Facilities (IDTF) led by a board-certified medical doctor.
Adopting Sensors and Technology
Engagement begins with subject enrollment.
The investigator, study coordinator and all study staff need to make sure that each study subject feels important and appreciated. This is successfully achieved by collaborating with our clinical team. Our clinical team members bring an average of 20-years of experience conducting and supporting clinical trials in various roles, including Clinical Research Assistants (CRAs). Moreover, our team of experienced technicians receive and analyze ECGs 24 hours per day, 7 days per week, 365 days per year.
We are committed to reducing costs while driving higher study subject compliance, changing the paradigm in clinical trials, helping study sponsors move away from the traditional “study subject to study site” requirements and supporting pragmatic trials and real-world evidence requirements.
Preventice’s portfolio of monitors supports different service types for all phases of clinical drug development studies, device comparison studies, and new clinical management methodologies. The premier Mobile Cardiac Telemetry (MCT) service type provides beat-to-beat, near real-time analysis, automatic arrhythmia detection and wireless ECG transmission. The trans-telephonic, post-event monitoring service provides the least burden for monitoring study subjects. It is common practice to use Holter devices for continuous data acquisition per protocol requirements.